Prostate
cancer - Health Hot Line - race as risk factor
- Brief Article |
PROSTATE cancer is the most common cancer among African-American
men and the second biggest cancer killer of African-American
men.
African-American men are 70 percent more likely to
develop the disease and twice as likely to die from
it than their White counterparts. The American Cancer
Society estimates that 25,300 African-American men were
diagnosed with prostate cancer in 2001, and that 6,100
died.
Experts say that race is a surrogate factor in the
disparity between Black and White prostate cancer rates.
Blacks are more likely to be poorer, more likely to
lack access to adequate health care, more likely to
eat the wrong kinds of food and more likely to forego
early screenings. "Prostate cancer is no different
in Black men than in White men," says Dr. Stephen
B. Thomas, Director of the Center for Minority Health
at the University of Pittsburgh. "The difference
is in the social context in which this disease is being
addressed."
Prostate cancer is not a death sentence, Early detection
and treatment can halt prostate cancer before it reaches
an advanced stage, African-American men 45 or older
should begin taking an annual prostate-specific antigen
test (PSA) along with a digital rectal exam and have
regular checkups. Those with fathers or brothers with
the disease should start at age 40. If prostate cancer
is detected at an early stage, it can be treated with
surgery or radiation and chemotherapy. Your doctor can
help you weigh the advantages and possible disadvantages
of the two major options. Within recent years, specialists
have developed new ways of treating the disease through
brachytherapy, or seed implants. Doctors inject 70 to
150 radioactive seeds the size of a rice grain into
the prostate gland. The seeds' radiation kills cancer
cells throughout the entire gland.
|